Dyne Therapeutics logo

Dyne Therapeutics

Dyne Therapeutics is an Antibody-Oligonucleotide Treatments for Muscle Diseases founded in 2018.

3

Funding Rounds

$215.7m

Money raised

Overview

Dyne Therapeutics is an Antibody-Oligonucleotide Treatments for Muscle Diseases founded in 2018.

Funding series

Funding Series Analysis

The company Dyne Therapeutics has raised a total of $50m in funding over 3 rounds.

Key Insights:

  • Dyne Therapeutics Series A round, April 2019: $50m
  • Dyne Therapeutics, Inc. funding round, August 2020: $115.7m
  • Dyne Therapeutics funding round, April 2019: $50m
Dyne Therapeutics logo
Dyne Therapeutics Series A round, April 2019 $50m
Dyne Therapeutics logo
Dyne Therapeutics, Inc. funding round, August 2020 $115.7m
Dyne Therapeutics logo
Dyne Therapeutics funding round, April 2019 $50m

Industries

Dyne Therapeutics is active in the following industries:
  • Rare disease
  • Industrial Biotechnology
  • Engineering
  • Biotechnology
  • Biomedical engineering
  • Biology
  • Technology